Ticker Details
OraSure Technologies, Inc. OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.
IPO Date:	March 17, 1992
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$295.02M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 2.52%
Avg Daily Range (30 D):	$0.15 | 3.64%
Avg Daily Range (90 D):	$0.11 | 3.13%

Institutional Daily Volume
Avg Daily Volume:	.55M
Avg Daily Volume (30 D):	.63M
Avg Daily Volume (90 D):	.52M

Trade Size
Avg Trade Size (Sh.):	143
Avg Trade Size (Sh.) (30 D):	101
Avg Trade Size (Sh.) (90 D):	111

Institutional Trades
Total Institutional Trades:	1,976
Avg Institutional Trade:	$1.27M
Avg Institutional Trade (30 D):	$1.68M
Avg Institutional Trade (90 D):	$1.03M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.24M
Avg Closing Trade (30 D):	$1.68M
Avg Closing Trade (90 D):	$1.4M
Avg Closing Volume:	134.92K

News

May 28, 2026 @ 4:07 PM Is Co-Diagnostics National Security’s Next ... Source: Jeffrey Neal Johnson

May 6, 2026 @ 10:27 PM OraSure (OSUR) Q1 2026 Earnings Transcript Source: Motley Fool Transcribing

Apr 17, 2026 @ 12:10 AM OraSure Technologies Appoints John D. Bertrand to ... Source: Na

Apr 3, 2026 @ 7:15 AM Drug Screening Market Trends 2026–2031: Chr... Source: Mordor Intelligence

Feb 3, 2026 @ 1:00 PM OTC/DTC Infectious Disease Diagnostics Research Re... Source: Researchandmarkets.Com

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.04	$-.32	$-.27
Diluted EPS	$-1.04	$-.32	$-.27
Revenue	$113.02M	$27.93M	$26.76M
Gross Profit	$47.7M	$11.8M	$10.97M
Net Income / Loss	$-75.07M	$-22.38M	$-19.29M
Operating Income / Loss	$-77.49M	$-23.27M	$-20.1M
Cost of Revenue	$65.31M	$16.12M	$15.8M
Net Cash Flow	$-73.55M	$-21.09M	$-18.53M
PE Ratio